We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENR icon
551
Energizer
ENR
$1.5B
$2.27M 0.01%
+58,057
New +$2.66M
OKTA icon
552
Okta
OKTA
$26.2B
$2.27M 0.01%
+10,608
New +$2.21M
GILD icon
553
Gilead Sciences
GILD
$165B
$2.27M 0.01%
35,841
-71,433
-67% -$4.95M
GBCI icon
554
Glacier Bancorp
GBCI
$6.35B
$2.25M 0.01%
70,323
-103,848
-60% -$3.59M
OGS icon
555
ONE Gas
OGS
$4.96B
$2.21M 0.01%
+32,041
New +$2.36M
IVC
556
DELISTED
Invacare Corporation
IVC
$2.2M 0.01%
292,796
-123,671
-30% -$857K
YETI icon
557
Yeti Holdings
YETI
$3.99B
$2.19M 0.01%
48,417
-347,759
-88% -$16.5M
ABG icon
558
Asbury Automotive
ABG
$3.78B
$2.19M 0.01%
22,509
+2,929
+15% +$296K
CDK
559
DELISTED
CDK Global, Inc.
CDK
$2.19M 0.01%
50,252
-140,463
-74% -$6.24M
MDC
560
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.18M 0.01%
50,027
+37,743
+307% +$1.5M
ABMD
561
DELISTED
Abiomed Inc
ABMD
$2.17M 0.01%
7,840
-1,939
-20% -$559K
SYNH
562
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.15M 0.01%
+40,520
New +$2.41M
PWR icon
563
Quanta Services
PWR
$99.4B
$2.15M 0.01%
+40,593
New +$1.89M
KDMN
564
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.14M 0.01%
546,356
-214,802
-28% -$902K
TXMD icon
565
TherapeuticsMD
TXMD
$24M
$2.13M 0.01%
27,012
+12,445
+85% +$992K
LII icon
566
Lennox International
LII
$14.6B
$2.13M 0.01%
+7,819
New +$2.09M
QNCX icon
567
Quince Therapeutics
QNCX
$30M
$2.1M 0.01%
210
-86
-29% -$782K
ARVN icon
568
Arvinas
ARVN
$588M
$2.1M 0.01%
88,739
+42,152
+90% +$1.22M
INSW icon
569
International Seaways
INSW
$4.48B
$2.09M 0.01%
143,298
-59,006
-29% -$985K
MNDT
570
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2.09M 0.01%
169,513
+49,446
+41% +$677K
MORF
571
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$2.09M 0.01%
76,366
TRMB icon
572
Trimble
TRMB
$13.6B
$2.09M 0.01%
+42,832
New +$2.05M
RPAY icon
573
Repay Holdings
RPAY
$317M
$2.08M 0.01%
88,437
-32,042
-27% -$777K
ONEW icon
574
OneWater Marine
ONEW
$205M
$2.07M 0.01%
101,108
+91,251
+926% +$2.31M
PSN icon
575
Parsons
PSN
$4.93B
$2.06M 0.01%
+61,434
New +$2.13M

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.